Navigation Links
Sangui BioTech Files Three 2007 Quarterly Reports, Sales Increased, Losses Continue
Date:6/20/2008

WITTEN, Germany, June 20 /PRNewswire-FirstCall/ -- Sangui BioTech International, Inc., has now filed its quarterly reports on Form 10QSB with the SEC covering the quarters ended September 30, 2006; December 31, 2006, and March 31, 2007. In the first nine month of its 2007 financial year the company generated sales of approximately USD 345,000 as compared to approximately USD 95,000 in the first nine months of FY 2006. Operating expenses amounted to almost USD 600,000. The increase as compared to the USD 356,000 in the previous year period is due to increased efforts to expand operations to international markets. The company incurred a net loss of approximately USD 486,000. Sangui used cash in operating acitivities of approximately USD 457,000 (2006 period: approximately USD 242,000). The company's accumulated deficit amounted to USD 22.3 million as of March 31, 2007.

Apart from the contribution margin generated from sales of its cosmetics and wound management products, operations in the first nine months of FY 2007 were financed by investments from several European investors in the amount of approximately USD 543,000. In accordance with US-GAAP the amount is shown as Foreign currency translation adjustments in the profit-and-loss statement and as Effect of exchange rate changes in the cash-flow statement respectively.

In the first nine months of its financial year 2008 (July 1, 2007 through March 31, 2008), Sangui BioTech International, Inc., generated hardly any sales. The company invested in identifying and establishing new sales opportunities in international markets, to wit Mexico and the Arab countries, as well as in the approval process of its Hemospray wound spray in accordance with European, Mexican and US regulations. Ensuing losses were financed by continued investments from several European investors.

SanguiBioTech GmbH is a wholly owned subsidiary of Sangui BioTech International, Inc. ('/>"/>

SOURCE Sangui BioTech International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Biotech Finishes on a High in August, Burrill Report Says
3. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
4. Spectrum Pharmaceuticals to Present at the Biotechnology Industry Organization Investor Forum
5. Biotech delists shares from TSXV, continues OTCBB trading
6. Frutarom Gewurzmuller and Blessing Biotech Acquisition Conference Call Scheduled for Monday, October 15, 2007
7. MichBio Announces Formation of Biotechnology Legislative Caucus
8. Oncolytics Biotech Inc. announces approval for UK clinical trial
9. Not just humans benefit from animal biotechnology
10. Biotech adds Central American markets to Sucanon distribution
11. GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2014)... Wisconsin (PRWEB) September 03, 2014 QueenBeeTickets.com ... that are scheduled for availability September 3. Onsales to the ... alternative metal bands are joining forces to tour this year ... to enjoy the best that the groups have to offer. ... huge number of concertgoers residing in North America. The majority ...
(Date:9/3/2014)... 03, 2014 “Home Remedies For Wrinkles ... report created by Tiffany Chou on the site Vkool.com ... problems including wrinkles and age spots . In ... some common causes of wrinkles and age spots such ...     Sun exposure: excessive exposure to the midday sun ...
(Date:9/3/2014)... In light of the continuous number of ... , a nationally esteemed personal injury law firm, believes ... is extremely important. The firm continues to follow ... sponsoring a website, designed as a resource to house ... to financial compensation. , Among those vehicles included in ...
(Date:9/3/2014)... Ohio Presbyterian Retirement Services ... services for older adults, has appointed Aric Arnett as ... , (Sarah Moore HCC) effective Sept. 15, 2014. , ... health care industry, including serving as the administrator for ... Company and HCR Manor Care. Arnett has been serving ...
(Date:9/3/2014)... While the Affordable Care Act provides ... the goal of offering better quality care at ... increasing scrutiny of hospital-physician transactions to ensure they ... This increased scrutiny resulted in the first-ever antitrust ... physician practice earlier this year. , ...
Breaking Medicine News(10 mins):Health News:Slipknot & Korn Presale Tickets for the Prepare for Hell 2014 Tour On Sale at Reduced Prices at QueenBeeTickets.com 2Health News:“Home Remedies For Wrinkles And Age Spots On Face And Body,” A New Report On Vkool.com, Reveals Natural And Effective Methods For Dealing With Skin Problems 2Health News:Flood Law Group Spreads Awareness in Wake of Most Recent GM Recall Announcement 2Health News:Arnett to Lead Delaware’s Sarah Moore Health Care Center 2Health News:Recent Becker’s Article Addresses Antitrust and Hospital Acquisition of Physician Practices 2
... HealthDay Reporter , MONDAY, Feb. 7 (HealthDay News) -- Feeding ... their IQ, while a diet rich in vitamins and nutrients ... particularly true during the first three years of life when ... speculate that good nutrition may promote brain growth and cognitive ...
... 8 (HealthDay News) -- As many as 75 percent of ... have serious consequences for patients, including delayed or missed diagnoses ... analyzed 12 international studies and found that between 20 percent ... percent and 75 percent of tests on emergency care patients, ...
... the controversial health care reform act will be somewhat muted ... an impact that seniors will discover that there is plenty ... Illinois expert on elder law cautions in published research. ... Patient Protection and Affordable Care Act of 2010 are a ...
... are either admitted to hospital suffering malnutrition, or become ... stay and health care costs. In her ... Nutrition & Dietetics , Dr Karen Charlton said ... not considered a clinical priority in hospitals and aged ...
... trauma is due to damage caused the overproduction of a ... been impossible, until now, as many drugs don,t cross the ... as intended. But a method originally devised at the Weizmann ... to avert such glutamate-induced harm. Prof. Vivian I. ...
... , MONDAY, Feb. 7 (HealthDay News) -- Smoking marijuana ... analysis of previously published research suggests. Among people ... pot developed the illness almost three years earlier than ... speculated that marijuana may actually cause psychosis in some ...
Cached Medicine News:Health News:Processed, Fatty Foods May Dumb Down Your Kids: Study 2Health News:Processed, Fatty Foods May Dumb Down Your Kids: Study 3Health News:Elder law expert: Health care reform act a mixed bag for seniors 2Health News:Elder law expert: Health care reform act a mixed bag for seniors 3Health News:Malnutrition: A skeleton in the health care closet 2Health News:Hope for stroke victims 2Health News:Pot Use Might Speed Onset of Psychosis: Study 2Health News:Pot Use Might Speed Onset of Psychosis: Study 3
(Date:9/2/2014)... -- Perrigo Company plc, a public limited company incorporated under ... Company "), today announced that it is offering to exchange ... Senior Notes due 2016 (the " 2016 Exchange Notes "), ... " 2018 Exchange Notes "), $800,000,000 of its new 4.00% ... and $400,00,000 of its new 5.30% Senior Notes due 2043 ...
(Date:9/2/2014)... CALGARY, Alberta , September 2, 2014 ... der "State of the Art and Featured Research Session" ... Resverlogix Corp. (TSX: RVX) gab heute bekannt, dass Dr. Jan ... beim Kongress des europäischen Kardiologenverbandes (ESC) 2014 in ... In seinem Vortrag mit dem Titel " Effects of ...
(Date:9/2/2014)... New York , September 2, 2014 /PRNewswire/ ... report published by Transparency Market Research "Latin America ... Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility Assist ... and Telemedicine, Respiratory Therapy, Infusion Therapy and Unskilled ... Growth, Trends and Forecast, 2014 - 2020" the ...
Breaking Medicine Technology:Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 2Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 3Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 4RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 2RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 3RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 4RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 5RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 6Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6
... 2011 PediaVision today announced that Loma Linda ... the State of California to receive the revolutionary ... University,s Department of Ophthalmology is offering free vision ... the support of First 5 Riverside , ...
... Calif., Sept. 29, 2011 Synthetic Genomics Vaccines, Inc. ... generation vaccines using genomic sequencing and synthetic genomic technologies, ... appointed as president.  Dr. Farah brings extensive vaccine expertise ... management experience in the biotechnology industry to SGVI. ...
Cached Medicine Technology:Loma Linda University Expands Vision Screening Program With Revolutionary New Screening Device, Spot 2Loma Linda University Expands Vision Screening Program With Revolutionary New Screening Device, Spot 3Loma Linda University Expands Vision Screening Program With Revolutionary New Screening Device, Spot 4Synthetic Genomics Vaccines, Inc. Hires Vaccine Executive Sammy J. Farah as President 2
... Metrikas pager-sized A1cNow ... technology to provide healthcare ... access to quantitative A1C ... indicator of diabetes management ...
... Vein Treatment. It is estimated that 25% of ... veins. In the United States, more than half ... from painful and unsightly venous disease., The VenaCure ... vascular therapy for the treatment of varicose veins. ...
Inquire...
Inquire...
Medicine Products: